Structure and Composition
1 ampoule with 1 ml injection solution contains 2-ethyl-6-methyl-3-hydroxypyridine hydrochloride (emoxipine) 0.01 g; 10 pieces per pack.
Mode of action – retinoprotektivnoe.
It protects the retina from the damaging effect of high light intensity, promotes the resorption of intraocular bleeding, reduces the permeability of capillaries, reduces blood clotting, increases the resistance to cerebral hypoxia and ischemia.
Intraocular hemorrhage, diabetic retinopathy, central chorioretinal dystrophy, thrombosis of the retina central vein of the eye and its branches, post-traumatic hemorrhage complicated by myopathy, glaucoma, acute and chronic disorders of cerebral circulation ischemic and hemorrhagic nature. Protection retina by exposure to high intensity light (laser and sunburn, laser photocoagulation).
Excitation (short), drowsiness, increased blood pressure, rash, local reactions: pain, burning sensation, itching, redness, induration paraorbital tissues.
Dosing and Administration
Retrobulbarno – 0.5 ml of a 1% solution of 1 times a day for 10-15 days; parabulbarno and subkonyunktivalno – by 0.2-0.5 ml of 1 times a day for 10-30 days. To protect retinal laser photocoagulation eye when administered retrobulbarly 0.5 ml per day and for 1 hour to coagulate. Then apply 0.5 ml retrobulbarno for 2-10 days every 1 day. In neurology – / m to 5.3 ml for 10-30 days 2-3 times per day.
Do not mix with others. Injecting equipment in the same syringe.
In the dark place at a temperature no higher than 25 ° C.
Keep out of the reach of children.
The shelf life
Do not use beyond the expiration date printed on the package.
|The purpose of the medication||Anti-aggregants|